2014
DOI: 10.1530/eje-14-0112
|View full text |Cite
|
Sign up to set email alerts
|

External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals

Abstract: Background and aims: Simple clinical algorithms including the fatty liver index (FLI) and lipid accumulation product (LAP) have been developed as surrogate markers for non-alcoholic fatty liver disease (NAFLD), constructed using (semi-quantitative) ultrasonography. This study aimed to validate FLI and LAP as measures of hepatic steatosis, as determined quantitatively by proton magnetic resonance spectroscopy ( 1 H-MRS).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
132
1
6

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 145 publications
(144 citation statements)
references
References 30 publications
5
132
1
6
Order By: Relevance
“…Complete objective monitoring of physical activity throughout ensured that the baseline criteria of >10,000 steps/day was met and likewise~1500 steps/day (>80% step reduction) during inactivity; habitual activity was monitored during the final 14 days, with no instruction or guidance; further, we characterised the time participants spent in domains of activity. Moreover, the participants were comprehensively phenotyped, including all measures of the metabolic syndrome, region-specific distribution and quantification of lean muscle and adipose tissue by DXA, and liver fat was quantified by 1 H-MRS, a highly sensitive non-invasive method [35].…”
Section: Discussionmentioning
confidence: 99%
“…Complete objective monitoring of physical activity throughout ensured that the baseline criteria of >10,000 steps/day was met and likewise~1500 steps/day (>80% step reduction) during inactivity; habitual activity was monitored during the final 14 days, with no instruction or guidance; further, we characterised the time participants spent in domains of activity. Moreover, the participants were comprehensively phenotyped, including all measures of the metabolic syndrome, region-specific distribution and quantification of lean muscle and adipose tissue by DXA, and liver fat was quantified by 1 H-MRS, a highly sensitive non-invasive method [35].…”
Section: Discussionmentioning
confidence: 99%
“…The fatty liver index (FLI) [5], the hepatic steatosis index (HSI) [6] and lipid accumulation product (LAP) [7] have been derived and utilized to screen hepatic steatosis in large epidemiologic studies or identify potential patients for further examination in clinical practice. The evaluation of the indexes' diagnostic performance has been reported in Europe [8] and Asia [9,10] over the past decade; however, external validation of them in western China is rare.…”
mentioning
confidence: 99%
“…NAFLD was diagnosed using the fatty liver index (FLI) score. FLI requires for calculation BMI, WC, triglycerides, and GGT [13]. A FLI score > 60 is considered to be suggestive for the presence of NAFLD [13].…”
Section: Assay and Indices Assessmentmentioning
confidence: 99%
“…The gold standard for NAFLD diagnosis is the liver biopsy but its invasive nature limits its use. Fatty liver index (FLI) score [12] is a noninvasive method widely used in epidemiological studies for NAFLD screening, showing good sensitivity compared with magnetic resonance spectroscopy for detecting fatty liver [13].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation